REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 85 filers reported holding REGULUS THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $123,000 | -3.1% | 37,144 | -15.7% | 0.00% | 0.0% |
| Q2 2016 | $127,000 | -56.8% | 44,037 | +3.7% | 0.00% | -50.0% |
| Q1 2016 | $294,000 | -27.0% | 42,476 | -8.1% | 0.00% | -20.0% |
| Q4 2015 | $403,000 | +45.5% | 46,212 | +9.2% | 0.01% | +25.0% |
| Q3 2015 | $277,000 | -43.0% | 42,302 | -4.6% | 0.00% | -42.9% |
| Q2 2015 | $486,000 | -34.3% | 44,333 | +1.5% | 0.01% | -22.2% |
| Q1 2015 | $740,000 | +30.1% | 43,671 | +23.0% | 0.01% | +28.6% |
| Q4 2014 | $569,000 | +199.5% | 35,494 | +27.6% | 0.01% | +133.3% |
| Q3 2014 | $190,000 | -28.3% | 27,809 | -15.8% | 0.00% | 0.0% |
| Q2 2014 | $265,000 | -32.2% | 33,009 | -23.9% | 0.00% | -40.0% |
| Q1 2014 | $391,000 | +177.3% | 43,394 | +127.5% | 0.01% | +150.0% |
| Q4 2013 | $141,000 | – | 19,071 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 327,350 | $2,943,000 | 1.62% |
| HealthCor Management, L.P. | 1,575,000 | $14,207,000 | 0.86% |
| Cormorant Asset Management, LP | 200,000 | $1,804,000 | 0.42% |
| BVF INC/IL | 184,999 | $1,669,000 | 0.26% |
| Verity Asset Management, Inc. | 28,410 | $244,000 | 0.25% |
| Callan Capital, LLC | 80,478 | $726,000 | 0.24% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 225,000 | $2,029,000 | 0.22% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 61,846 | $558,000 | 0.05% |
| LMR Partners LLP | 11,815 | $106,000 | 0.02% |
| Weiss Multi-Strategy Advisers LLC | 70,000 | $631,000 | 0.01% |